Education
About Us
Working with TipRanks
Follow Us
Albertson Tina M. Insider Profile
4 Followers
Albertson Tina M., Chief Medical Officer at Lyell Immunopharma, holds 4.05K shares in Lyell Immunopharma (Ticker: LYEL), holds 14.59K shares in Caribou Biosciences (Ticker: CRBU). Most recently, Albertson Tina M. ― shares of Lyell Immunopharma on ― for an estimated value of ―.
Albertson Tina M. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Albertson Tina M. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Albertson Tina M.
Albertson Tina M.'s Trading History
Lyell Immunopharma
―
Chief Medical Officer
―
$3.01K
Caribou Biosciences
Feb 21, 2025
CMO
Uninformative Buy
―
$16.92K
List of latest transactions for each holding click on a transaction to see Albertson Tina M.'s performance on stock
You May Also Like
Albertson Tina M. insider profile FAQ
What is the percentage of profitable transactions made by Albertson Tina M.?
The percentage of profitable transactions made by Albertson Tina M. is ―.
What is the average return per transaction made by Albertson Tina M.?
The average return per transaction made by Albertson Tina M. is ―.
What stocks does Albertson Tina M. hold?
Albertson Tina M. holds: LYEL, CRBU stocks.
What was Albertson Tina M.’s latest transaction?
Albertson Tina M. latest transaction was an Uninformative Buy of ―.
What was Albertson Tina M.'s most profitable transaction?
Albertson Tina M.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Albertson Tina M.'s role in Lyell Immunopharma?
Albertson Tina M.'s role in Lyell Immunopharma is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.